Azenta Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
This is Paul Knight at KeyBanc. I'm the analyst in life science technology. With us today, we have Lindon Robertson, the Chief Financial Officer of Azenta; and Sara Silverman, who's Head of Investor Relations. I still want to call it Brooks, but I won't after this meeting, Lindon. What we'll do is, I know you're going to do a little bit of an overview here. And on our chat, you are able to ask questions. In addition, you can e-mail myself at [email protected]. So with that, Lindon, I'll let you begin.
Well, that's great. Thanks for having us again. And we love your conferences, and it's been a really good day for us. And as you said, we are Azenta these days, and we finalized the separation from our semiconductor legacy on February 1. So we're a complete stand-alone life sciences company.
First, we pay a little attention here to the safe harbor statement. We won't make adjustments to our comments
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
